Psilocybin and Psychedelics in Missouri: Pending Legislation
This page tracks the current legal status of psilocybin, psychedelics, and entheogens in Missouri. Status is updated from our legislation sync, with citations to the underlying bills and policy decisions.
Missouri House passed HB 1717 in early 2026, requiring the state to conduct a study on using psilocybin for treating PTSD, depression, and other conditions. The bill is now in the Senate for first reading. This represents a breakthrough after four years of legislative attempts in Missouri.
HB 1717 passed the Missouri House in 2026 — first time a psilocybin bill passed a chamber Bill now in the Senate for first reading Requires state-funded study on psilocybin for PTSD, depression, and other conditions Breakthrough after four years of legislative attempts Previous HB 2648 (2024) helped build momentum Bipartisan support demonstrated by House passage
Laws change. Always verify current status with primary sources before acting on this information, especially when traveling across state lines.